Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Mechanisms of action of psychotropic medication > Flashcards

Mechanisms of action of psychotropic medication Flashcards

1
Q

Citalopram

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Paroxetine

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fluoxetine

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sertraline

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Escitalopram

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Venlafaxine

A

SNRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Duloxetine

A

SNRI
Blocks norepinephrine, serotonin, and dopamine reuptake pumps
Desensitises serotonin 1A receptors and beta adrenergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Reboxetine

A

Selective noradrenaline reuptake inhibitor (NARI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mirtazapine

A

Noradrenergic and specific serotonergic antidepressant (NaSSA)
Antagonist at alpha2 adrenergic inhibitory receptors, antagonist of serotonin 5HT2 and 5HT3 receptors, and histamine receptor antagonist
Preferentially blocks histaminic receptor at low doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Moclobemide

A

Reversible inhibitor of MAO-A selectively - RIMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Trazodone

A

Serotonin agonist and reuptake inhibitor - SARI

Blocks the serotonin reuptake pump, and is an antagonist at 5HT2A and 5HT2C - mixed serotonin agonist/antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chlorpromazine

A

Typical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Flupenthixol

A

Typical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zuclopenthixol

A

Typical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sulpiride

A

Typical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Haloperidol

A

Typical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clozapine

A 
Atypical antipsychotic
5HT2>D2 antagonist
D4 receptor blocker
5HT6 receptor blocker
Weak D1 and D2 affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risperidone

A

Atypical antipsychotic
D2 antagonist
5HT2A antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Olanzapine

A

Atypical antipsychotic
Dopamine antagonist
5HT2a antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Quetiapine

A

Atypical antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Amisulpride

A

Atypical antipsychotic

D2-like selective antagonist (D2=D3>D4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Aripiprazole

A

Atypical antipsychotic
5HT1a partial agonist
D2 partial agonist
5HT2A antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

St John’s Wort

A

Weak MAOI

Weak SNRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Agomelatine

A

Melatonergic agonist

5-HT2C antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Bupropion

A

Norepinephrine dopamine reuptake inhibitor

Nicotinic acetylcholine receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Donepezil

A

Selective reversible acetylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Rivastigmine

A

Reversible acetylcholinesterase inhibitor

Butyrylcholinesterase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Galantamine

A

Competitive reversible acetylcholinesterase inhibitor

Binds allosterically to the nicotinic acetylcholine receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Memantine

A

Non-competitive NMDA antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Valproate

A

GABA agonist/potentiator

NMDA antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Gabapentin

A

Unknown but binds to voltage activated calcium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Topiramate

A

GABA agonist
NMDA antagonist
Na channel stabiliser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Carbamazepine

A

Na channel stabiliser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Phenytoin

A

Na channel stabiliser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Lamotrigine

A

Na channel stabiliser

NMDA antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Pregabalin

A

Alpha 2 delta voltage gated calcium channel ligand

35
Q

Z-drugs

A

GABA-A agonist

36
Q

Buspirone

A

5HT1A partial agonist
Partial agonist on serotonin 5-HT1a receptors; full agonist at pre-synaptic receptors and partial agonist at post-synaptic receptors; reduces the firing of serotonin-producing neurons
Presynaptic agonism leads to antianxiety effects
Postsynaptic agonism leads to antidepressant effects

37
Q

Flumazenil

A

GABA-A antagonist

38
Q

Lurasidone

A 
Atypical antipsychotic
D2 antagonist
5HT2A blocker
Partial 5HT1A agonist
5HT7 antagonist
39
Q

Lofexidine

A

Alpha 2 agonist

40
Q

Clonidine

A

Alpha 2 agonist

41
Q

Buprenorphine

A

Mu opioid receptor partial agonist

42
Q

Naloxone

A

Opioid antagonist at mu, delta and kappa

43
Q

Atomoxetine

A

Noradrenaline reuptake inhibitor

44
Q

Varenicline

A

Nicotinic receptor partial agonist

45
Q

Disulfiram

A

Irreversible binder to acetalydehyde dehydrogenase

Causes accumulation of acetaldehyde following ingestion of alcohol

46
Q

Acamprosate

A

NMDA glutamate receptor antagonist
Synthetic taurine analogue
Allosteric modulator at GABA-A

47
Q

Selegiline

A

Irreversible MAO B inhibitor

MAO A inhibitor at higher doses

48
Q

Sildenafil

A

cGMP-specific phosphodiesterase type 5 inhibitor

49
Q

Naltrexone

A

Reversible competitive antagonist at mu and kappa opioid receptors

50
Q

Methadone

A

Full mu agonist

51
Q

Barbiturates

A

Increase duration of chloride channel opening to potentiate the effect of GABA at GABAa receptors

52
Q

Benzodiazepines

A

Increase the frequency of chloride channels to potentiate the effect of GABA at GABAa receptors - GABA a positive allosteric modulators

53
Q

Carbamazepine

A

Binds to sodium channels to increase their refractory period

54
Q

Donepezil

A

Reversible acetylcholinesterase inhibitor which prevents cholinesterase from breaking down acetylcholine

55
Q

Galantamine

A

Reversible acetylcholinesterase inhibitor which prevents cholinesterase from breaking down acetylcholine, and binds allosterically to the nicotinic acetylcholine receptor

56
Q

Rivastigmine

A

Reversible acetylcholinesterase inhibitor which prevents cholinesterase from breaking down acetylcholine and butyrylcholinesterase inhibitor

57
Q

Memantine

A

NMDA receptor antagonist that blocks the effects of pathologically raised levels of glutamate

58
Q

Flumazenil

A

Selective GABAa receptor antagonist that reverses the effects of benzodiazepines through competitive interaction

59
Q

Zopiclone

A

Similar to benzodiazepines binds to GABAa receptor sites to enhance the action of GABA

60
Q

Opioids

A

Act on opioid receptors µ, k, and δ (G-protein coupled receptors). Key receptor subtype is µ which causes most of the effects and side-effects

61
Q

Methadone

A

Full agonist targeting µ receptors with some action against k and δ

62
Q

Buprenorphine

A

Partial agonist targeting µ largely

63
Q

Naloxone

A

Antagonist targeting all opioid receptors

64
Q

Naltrexone

A

Reversible competitive antagonist µ and ĸ receptors

65
Q

Bromocriptine

A

Dopamine receptor agonist

66
Q

Ropinirole

A

Dopamine receptor agonist

67
Q

Carbergoline

A

Dopamine receptor agonist

68
Q

Levodopa

A

Crosses the blood brain barrier to directly increase dopamine concentrations

69
Q

Selegeline

A

Selectively inhibits MAO-B to prevent the breakdown of dopamine

70
Q

Moclobemide

A

Selective, reversible inhibitor of MAO-A which causes an increase in noradrenaline, dopamine and especially sertraline

71
Q

Entacapone

A

Selective and reversible inhibitor of COMT - COMT breaks down dopamine so entacapone reduces breakdown of dopamine

72
Q

Topiramate

A

Inhibits voltage gated sodium channels which suppresses action potentials; increases GABA levels

73
Q

Varenicline

A

Selective nicotine-receptor partial agonist

74
Q

Bupriopion

A

Noradrenaline-dopamine reuptake inhibitor and nicotinic acetylcholine receptor antagonist

75
Q

Agomelatine

A

Melatonin receptor antagonist, and serotonin 5HT2C and 5HT2B receptor antagonist

76
Q

Sodium Valproate

A

GABA agonist, possibly by inhibiting GABA degradative enzymes, blocks voltage gated sodium channels

77
Q

Methadone

A

Pure mu agonist

78
Q

Milnacipran

79
Q

Nefazodone

80
Q

Cyproheptadine

A

Antagonist of histamine H1 receptors

81
Q

Vortioxetine

A

Serotonin transporter inhibition
5HT3 and 5HT7 receptor antagonist
5HT1A agonist
5HT1B/D weak partial agonist to antagonist

82
Q

Carbidopa

A

Inhibits DOPA decarboxylase - therefore inhibits the conversion of L-dopa to dopamine outside the CNS, which increases the amount of L-dopa in the body. L-dopa is able to cross the blood brain barrier so the result is higher concentrations of dopamine in the brain and less peripherally

83
Q

L-dopa

A

Acts as a precursor to dopamine

84
Q

Nalmefene

A

Opioid receptor antagonist/opioid receptor modulator

85
Q

SSRI mechanism of action

A

5HT1A agonism
5HT2 agonism
5HT3 agonism

86
Q

Malnicipran

87
Q

Sulpride

A

Atypical antipsychotic
Binds to auto-inhibitory D4 receptors - presynaptic D4 antagonism
D2 antagonism

Pharmacology (34 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions